利斯特里亚单细胞菌的腺类辅食体受损于细胞内和细胞外生长,但仍具有强大的免疫性
Ying Feng1, Mariya Lobanovska1, Jenna Vickery1
1Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, USA.
Infection and immunity
|September 5, 2025
概括
在Listeria monocytogenes中删除purA基因减弱了细菌,使其成为癌症免疫治疗的更安全候选者. PurA突变显示出独特的免疫细胞局部化,并增强了CD8+ T细胞的反应.
科学领域:
- 免疫学
- 微生物学
- 生物化学
背景情况:
- 由于其免疫性,Listeria monocytogenes是一种具有癌症治疗潜力的病原体.
- 基因删除,如actA,用于减弱L.单细胞原体,以开发安全的疫苗.
- 纯素生物合成对于细菌的生存和发病是必不可少的.
研究的目的:
- 研究purA基因在L. monocytogenes病毒性和免疫性中的作用.
- 评估purA删除对于开发基于L.单细胞体的免疫疗法的潜力.
- 将purA突变的安全性和有效性与已确定的减弱菌株 (actA) 进行比较.
主要方法:
- 在L. monocytogenes中构建和表征纯A删除突变.
- 对宿主细胞 (巨细胞) 和宿主液体 (血清,血液) 的细菌生长和生存进行评估.
- 在小鼠感染模型中评估细菌衰减和免疫反应,包括免疫细胞局部化和CD8+ T细胞反应.
主要成果:
- 在实验室和体内,PurA突变被减弱,宿主细胞细胞醇的生长有缺陷,并且无法在血清/血液中生长.
- 与actA突变体相比,purA突变体表现出明显的脏免疫细胞局部化.
- 与actA突变物相比,PurA突变物引起了更强大的CD8+T细胞反应.
结论:
- 腺酸合成酶 (PurA) 对于L. monocytogenes的致病性至关重要.
- 基于L. monocytogenes的癌症疫苗和免疫疗法的开发是一个有前途的策略.
- 与现有的减弱菌株相比,PurA突变具有明显的免疫优势.
相关概念视频
01:26Antigens Involved in Adaptive Immunity
750
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
750
01:23Cells of the Adaptive Immune Response
5.3K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
5.3K
01:22Development of Immunocompetence
484
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
484